|
1
|
Kufe DW: Mucins in cancer: Function,
prognosis and therapy. Nat Rev Cancer. 9:874–885. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kufe DW: MUC1-C oncoprotein as a target in
breast cancer: Activation of signaling pathway and therapeutic
approaches. Oncogene. 32:1073–1081. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Macao B, Johansson DG, Hansson GC and Härd
T: Autoproteolysis coupled to protein folding in the SEA domain of
the membrane-bound MUC1 mucin. Nat Struct Mol Biol. 13:71–76. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siddiqui J, Abe M, Hayes D, Shani E, Yunis
E and Kufe D: Isolation and sequencing of a cDNA coding for the
human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci
USA. 85:2320–2323. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 10:749–759. 2005. View
Article : Google Scholar
|
|
6
|
Ahmad R, Raina D, Trivedi V, Ren J, Rajabi
H, Kharbanda S and Kufe D: MUC1 oncoprotein activates the I kappaB
kinase complex and constitutive NF-kappaB signaling. Nat Cell Biol.
9:1419–1427. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahmad R, Raina D, Joshi MD, Kawano T, Ren
J, Kharbanda S and Kufe D: MUC1-C oncoprotein functions as a direct
activator of the nuclear factor-kappaB p65 transcription factor.
Cancer Res. 69:7013–7021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vinall LE, King M, Novelli M, Green CA,
Daniels G, Hilkens J, Sarner M and Swallow DM: Altered expression
and allelic association of the hypervariable membrane mucin MUC1 in
Helicobacter pylori gastritis. Gastroenterology. 123:41–49. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang L, Chen D, Liu D, Yin L, Kharbanda S
and Kufe D: MUC1 oncoprotein blocks glycogen synthase kinase 3
beta-mediated phosphorylation and degradation of beta-catenin.
Cancer Res. 65:10413–10422. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanoh A, Takeuchi H, Kato K, Waki M, Usami
K and Irimura T: Interleukin-4 induces specific pp-GalNAc-T
expression and alterations in mucin O-glycosylation in colonic
epithelial cells. Biochim Biophys Acta. 1780:577–584. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Byrd JC and Bresalier RS: Mucins and mucin
binding proteins in colorectal cancer. Cancer Metastasis Rev.
23:77–99. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johansson ME, Phillipson M, Petersson J,
Velcich A, Holm L and Hansson GC: The inner of the two Muc2
mucin-dependent mucus layers in colon is devoid of bacteria. Proc
Natl Acad Sci USA. 105:15064–15069. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feagins LA, Souza RF and Spechler SJ:
Carcinogenesis in IBD: Potential targets for the prevention of
colorectal cancer. Nat Rev Gastroenterol Hepatol. 6:297–305. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hollingsworth MA and Swanson BJ: Mucins in
cancer: Protection and control of the cell surface. Nat Rev Cancer.
4:45–60. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vincent A, Perrais M, Desseyn JL, Aubert
JP, Pigny P and Van Seuningen I: Epigenetic regulation (DNA
methylation, histone modifications) of the 11p15 mucin genes (MUC2,
MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene.
26:6566–6576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bu XD, Li N, Tian XQ, Li L, Wang JS, Yu XJ
and Huang PL: Altered expression of MUC2 and MUC5AC in progression
of colorectal carcinoma. World J Gastroenterol. 16:4089–4094. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
López-Ferrer A, Curull V, Barranco C,
Garrido M, Lloreta J, Real FX and de Bolós C: Mucins as
differentiation markers in bronchial epithelium. Squamous cell
carcinoma and adenocarcinoma display similar expression patterns.
Am J Respir Cell Mol Biol. 24:22–29. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A
and Yang PC: Sialyl Lewis antigens: Association with MUC5AC protein
and correlation with post-operative recurrence of non-small cell
lung cancer. Lung Cancer. 47:59–67. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duncan TJ, Watson NF, Al-Attari AH,
Scholefield JH and Durrant LG: The role of MUC1 and MUC3 in the
biology and prognosis of colorectal cancer. World J Sur Oncol.
5:312007. View Article : Google Scholar
|
|
21
|
Kocer B, Soran A, Erdogan S, Karabeyoglu
M, Yildirim O, Eroglu A, Bozkurt B and Cengiz O: Expression of
MUC5AC in colorectal carcinoma and relationship with prognosis.
Pathol Int. 52:470–477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mosli MH and Al-Ahwal MS: Colorectal
cancer in the kingdom of Saudi Arabia: Need for screening. Asian
Pac J Cancer Prev. 13:3809–3813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gado A, Ebeid B, Abdelmohsen A and Axon A:
Colorectal cancer in Egypt is commoner in young people: Is this
cause for alarm. Alexandria J Med. 50:197–201. 2014. View Article : Google Scholar
|
|
24
|
Greene FL: TNM staging for malignancies of
the digestive tract: 2003 changes and beyond. Semin Surg Oncol.
21:23–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sobin LH and Wittekind C: TNM
Classification of Malignant Tumours (6th). John Wiley & Sons.
Hoboken, NJ: 2002.
|
|
26
|
Hamilton SR and Aaltonen L: Tumours of
small intestine. In: World Health Organization Classification of
Tumours. Pathology and Genetics of Tumours of the Digestive System.
IARC Press. (Lyon). 69–91. 2000.
|
|
27
|
Rimm DL, Camp RL, Charette LA, Costa J,
Olsen DA and Reiss M: Tissue microarray: A new technology for
amplification of tissue resources. Cancer J. 7:24–31.
2001.PubMed/NCBI
|
|
28
|
Biemer-Hüttmann AE, Walsh MD, McGuckin MA,
et al: Mucin core protein expression in colorectal cancers with
high levels of microsatellite instability indicates a novel pathway
of morphogenesis. Clin Cancer Res. 6:1909–1916. 2000.PubMed/NCBI
|
|
29
|
Farhat MH, Barada KA, Tawil AN, Itani DM,
Hatoum HA and Shamseddine AI: Effect of mucin production on
survival in colorectal cancer: A case-control study. World J
Gastroenterol. 14:6981–6985. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baldus SE, Mönig SP, Hanisch FG, Zirbes
TK, Flucke U, Oelert S, Zilkens G, Madejczik B, Thiele J, Schneider
PM, et al: Comparative evaluation of the prognostic value of MUC1,
MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal
adenocarcinoma. Histopathology. 40:440–449. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Voloshanenko O, Erdmann G, Dubash TD,
Augustin I, Metzig M, Moffa G, Hundsrucker C, Kerr G, Sandmann T,
Anchang B, et al: Wnt secretion is required to maintain high levels
of Wnt activity in colon cancer cells. Nat Commun. 4:26102013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ajioka Y, Allison LJ and Jass JR:
Significance of MUC1 and MUC2 mucin expression in colorectal
cancer. J Clin Pathol. 49:560–564. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gratchev A, Siedow A, Bumke-Vogt C, Hummel
M, Foss HD, Hanski ML, Kobalz U, Mann B, Lammert H, Mansmann U, et
al: Regulation of the intestinal mucin MUC2 gene expression in
vivo: Evidence for the role of promoter methylation. Cancer
Lett. 168:71–80. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ookawa K, Kudo T, Aizawa S, Saito H and
Tsuchida S: Transcriptional activation of the MUC2 gene by p53. J
Biol Chem. 277:48270–48275. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Biemer-Hüttmann AE, Walsh MD, McGuckin MA,
Simms LA, Young J, Leggett BA and Jass JR: Mucin core protein
expression in colorectal cancers with high levels of microsatellite
instability indicates a novel pathway of morphogenesis. Clin Cancer
Res. 6:1909–1916. 2000.PubMed/NCBI
|
|
36
|
Lugli A, Zlobec I, Baker K, Minoo P,
Tornillo L, Terracciano L and Jass JR: Prognostic significance of
mucins in colorectal cancer with different DNA mismatch-repair
status. J Clin Pathol. 60:534–539. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rabassa ME, Croce M, Pereyra A and
Segal-Eiras A: MUC1 expression and anti-MUC1 serum immune response
in head and neck squamous cell carcinoma (HNSCC): A multivariate
analysis. BMC Cancer. 6:2532006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ahnen DJ, Wade SW, Jones WF, Sifri R,
Silveiras Mendoza J, Greenamyer J, Guiffre S, Axilbund J, Spiegel A
and You YN: The increasing incidence of young onset colorectal
cancer: A call to action. Mayo Clinic Proc. 89:216–224. 2014.
View Article : Google Scholar
|
